Loading chat...

CT SB00866

Bill

Official Source

Status

Introduced

2/22/2017

Primary Sponsor

General Law Committee

Click for details

Origin

Senate

2017 General Assembly

AI Summary

  • Establishes that if cannabidiol investigational products receive federal FDA approval or rescheduling as a prescription medication, they shall be automatically deemed approved as a prescription medication in Connecticut.

  • Applies the definition of "prescription medication" from Connecticut General Statutes Section 17b-499 to cannabidiol products.

  • Takes effect on July 1, 2017.

Legislative Description

An Act Concerning Cannabidiol Prescription Medication.

Last Action

File Number 87

3/16/2017

Committee Referrals

General Law2/22/2017

Full Bill Text

No bill text available